PFG Advisors

Position in GILD — Gilead Sciences, Inc.

CIK 1694435 Phoenix, AZ

Position in GILD

as of Jun 30, 2026 · filed Jul 16, 2026 Compact

Position Value

$348,066

-$181,400 QoQ

Shares Held

2,755

-27.5% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.05%

of 13F equity value

Holder Rank

#1,573

of 2,266 holders

Holding Since

Mar 2020

17 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

PFG Advisors holds $28,669,367 across 8 Drug Manufacturers - General names. GILD ranks #7 (1.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	28,720	$7,294,018
2	ABBV	AbbVie Inc.	22,305	$5,612,830
3	LLY	ELI LILLY & Co	4,488	$5,383,042
4	AMGN	Amgen Inc	14,633	$5,298,901
5	MRK	Merck & Co., Inc.	31,306	$4,022,821
6	PFE	Pfizer Inc	15,983	$384,870
7	GILD	Gilead Sciences, Inc. This page	2,755	$348,066
8	AZN	Astrazeneca PLC	1,713	$324,819

17 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$348,066	2,755	-27.5%	Shares	Sole	2026-07-16
2026-03-31	$529,466	3,799	+5.0%	Shares	Sole	2026-05-05
2025-12-31	$443,950	3,617	-42.3%	Shares	Sole	2026-01-27
2025-09-30	$695,304	6,264	+7.2%	Shares	Sole	2025-11-13
2025-06-30	$647,924	5,844	+48.1%	Shares	Sole	2025-08-07
2025-03-31	$442,037	3,945	-1.6%	Shares	Sole	2025-05-06
2024-12-31	$370,311	4,009	-1.3%	Shares	Sole	2025-02-07
2024-09-30	$340,474	4,061	-2.1%	Shares	Sole	2024-10-15
2024-06-30	$284,731	4,150	+37.7%	Shares	Sole	2024-08-08
2024-03-31	$220,702	3,013	-7.9%	Shares	Sole	2024-05-07
2023-12-31	$265,145	3,273	-2.6%	Shares	Sole	2024-01-19
2023-09-30	$251,873	3,361	+24.1%	Shares	Sole	2023-10-13
2023-06-30	$208,782	2,709	+0.5%	Shares	Sole	2023-07-20
2023-03-31	$223,687	2,696	+3.6%	Shares	Sole	2023-04-21
2022-12-31	$223,467	2,603	-60.2%	Shares	Sole	2023-01-30
2020-06-30	$503,187	6,540	+2.7%	Shares	Sole	2020-07-16
2020-03-31	$475,847	6,365	—	Shares	Sole	2020-04-29
No filing history on record for this holder in this stock.